DUBLIN, Jan. 17, 2024 /PRNewswire/ — The “Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” report has been added to ResearchAndMarkets.com’s offering.
Infusion Systems Pipeline Report provides comprehensive information about the Infusion Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Infusion systems are used to administer medication to a patient in critical care, emergency care, home care and trauma centres.
The report provides comprehensive coverage of the Infusion Systems currently under development, offering a deep dive into this vital healthcare sector. It meticulously examines the specifics of major pipeline products, encompassing thorough product descriptions, licensing agreements, collaboration details, and other essential developmental activities that are shaping the landscape of infusion systems.
Furthermore, the report scrutinizes the major players actively driving innovation in Infusion Systems, presenting a comprehensive catalog of their ongoing pipeline projects. This coverage spans the entire spectrum of development stages, ranging from early conceptualization to products in the approved and issued stages, delivering a holistic view of the evolving realm of infusion systems.
Additionally, the report furnishes essential clinical trial data pertinent to ongoing trials linked to these pipeline products. It also keeps stakeholders informed about the most recent developments within the infusion systems segment and the broader industry, ensuring that they stay abreast of the latest trends and advancements in this critical field.
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Infusion Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Infusion Systems Overview
3 Products under Development
3.1 Infusion Systems – Pipeline Products by Stage of Development
3.2 Infusion Systems – Pipeline Products by Segment
3.3 Infusion Systems – Pipeline Products by Territory
3.4 Infusion Systems – Pipeline Products by Regulatory Path
3.5 Infusion Systems – Pipeline Products by Estimated Approval Date
3.6 Infusion Systems – Ongoing Clinical Trials
4 Infusion Systems – Pipeline Products under Development by Companies
4.1 Infusion Systems Companies – Pipeline Products by Stage of Development
4.2 Infusion Systems – Pipeline Products by Stage of Development
5 Infusion Systems Companies and Product Overview
6 Infusion Systems- Recent Developments
7 Appendix
A selection of companies mentioned in this report includes
- 410 Medical Inc
- AbbVie Inc
- Acuros GmbH
- Adept Medical Ltd
- Agitated Solutions LLC
- Albireo Pharma Inc
- Alnylam Pharmaceuticals Inc
- Arnali, LLC
- Avoset Health Ltd
- Baxter Healthcare Corp
- Baxter International Inc
- Becton Dickinson and Co
- BioQ Pharma Inc
- ClearLine MD
- Cognos Therapeutics Inc
- Debiotech SA
- Eksigent Technologies, LLC
- Eli Lilly and Co
- EryDel SPA
- Flowonix Medical Inc
- Fluid Synchrony LLC
- Fluonic, Inc. (Inactive)
- Fresenius Medical Care AG & Co KGaA
- HAI Solutions Inc
- Hospira Inc
- ICU Medical Inc
- Infusense Corp
- Innofuse BV
- Innovative Health Sciences LLC
- Innovfusion Pte. Ltd.
- Intarcia Therapeutics Inc
- IRadimed Corp
- KORU Medical Systems Inc
- LifeMedix, LLC
- Lynntech Inc
- Massachusetts Institute of Technology
- Medical Device Creations Ltd.
- Medovate Ltd
- MonuMedical LLC
- Neurochase Ltd
- NexGen Medical Systems Inc
- Palyon Medical Corp (Inactive)
- Pavmed Inc
- PRO-IV Medical Ltd
- Ratio Inc
- Rice University
- Sensile Medical AG
- Shenox Pharmaceuticals LLC
- Shift Labs Inc
- SQ Innovation AG
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Starton Therapeutics Inc
- SteadyMed Therapeutics Inc
- StnDrd Infusion Corporation
- Supernus Pharmaceuticals Inc
- Terumo Corp
- ToucheMedical Ltd.
- TriSalus Life Sciences Inc
- Turnpoint Medical Devices Inc
- U-Needle BV
- Unilife Corporation
- United Therapeutics Corp
- University of Minnesota
- University of Southern California
- Zealand Pharma AS
For more information about this report visit https://www.researchandmarkets.com/r/io5tb6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
